Cannabinoids for Insomnia

Cannabis Changed Sleep—But Not How You’d Expect

June 8, 2026

As interest in the future of interventional psychiatry continues to grow, new findings in medicinal cannabis research are expanding conversations about potential alternatives for sleep disorders. Recent interventional psychiatry research has highlighted how cannabinoid-based treatments may influence the brain during sleep in ways that differ from traditional sleep medications.

Insomnia affects millions of adults worldwide and remains one of the most common sleep disorders. Persistent difficulty falling asleep or staying asleep can significantly affect mood, cognition, physical health, and overall quality of life. While cognitive behavioral therapy remains the recommended first-line treatment, many individuals seek faster solutions through medications or alternative therapies.

Why Patients Continue Seeking New Sleep Treatments

Conventional sleep medications can provide short-term benefits, but they are often associated with next-day grogginess, dizziness, memory problems, or concerns about long-term use. These limitations have contributed to growing interest in medicinal cannabis products as a possible option for improving sleep.

Despite widespread public use, relatively few controlled clinical trials have objectively measured how cannabis compounds affect the brain during sleep. Much of the existing evidence relies on patient reports rather than direct physiological measurements.

To address this gap, researchers conducted a randomized placebo-controlled crossover trial examining the effects of oral cannabinoids on sleep architecture and brain activity in adults diagnosed with insomnia disorder.

Using High-Density EEG To Study Cannabinoids For Insomnia

The study enrolled 20 adults with clinical insomnia who had not used cannabis within the previous three months. Participants received either a placebo or a cannabis oil containing 10 milligrams of tetrahydrocannabinol (THC) and 200 milligrams of cannabidiol (CBD) on separate study nights.

Researchers monitored participants overnight using high-density electroencephalography (EEG), employing a specialized cap equipped with 256 electrodes. This approach allowed investigators to observe detailed patterns of brain activity throughout multiple stages of sleep.

Unlike subjective sleep surveys, EEG recordings provide objective measurements of how the brain transitions through light sleep, deep sleep, and rapid eye movement (REM) sleep.

Key Findings Show Significant Changes In Sleep Architecture

The results revealed several notable effects of the cannabinoid formulation.

Participants experienced approximately 25 fewer minutes of total sleep compared to placebo nights. The treatment also reduced time spent in REM sleep by roughly 34 minutes and delayed the onset of REM sleep by more than one hour.

REM sleep is strongly associated with dreaming and emotional processing. The reduction observed in this study is consistent with previous findings showing that THC can suppress REM sleep activity.

Researchers also observed reductions in higher-frequency brain waves during lighter sleep stages, suggesting decreased cortical arousal. At the same time, slow-wave activity during deep sleep was reduced.

Because slow-wave sleep is often linked to physical restoration and recovery, these findings raise important questions about whether cannabinoid-induced sleep differs in quality from naturally occurring sleep.

What Brain Activity Revealed About Sleep Quality

High-density EEG recordings offered additional insight into how cannabinoids influence the sleeping brain.

During REM sleep, participants displayed increased fast-frequency activity in posterior brain regions. This pattern suggests a state of heightened neural activation despite remaining asleep.

These findings indicate that cannabinoids may not simply promote sedation. Instead, they appear to reshape the organization and timing of sleep stages while altering electrical activity across multiple brain networks.

The ability to measure these subtle changes demonstrates why advanced EEG technologies are becoming increasingly valuable tools in sleep and psychiatric research.

Limited Evidence Of Next-Day Cognitive Impairment

One of the most clinically relevant findings involved next-day functioning.

Participants completed attention, reaction time, and wakefulness assessments following both treatment conditions. Researchers found no statistically significant differences in objective cognitive performance between the cannabinoid and placebo groups.

Although participants reported feeling slightly more sleepy after receiving the cannabinoid treatment, their measured performance remained largely unchanged.

This distinction may be important for clinicians evaluating the balance between potential therapeutic benefits and concerns about daytime impairment.

Implications For Future Research

The study provides valuable evidence that cannabinoids can significantly alter sleep architecture and brain activity after a single dose. However, several limitations remain.

The sample size was small, and researchers only examined the effects of one night of treatment. Questions about long-term use, tolerance, withdrawal effects, and sustained clinical benefits remain unanswered.

Future studies will need to investigate how repeated cannabinoid use affects sleep quality over weeks or months and whether specific THC-to-CBD ratios produce different outcomes.

As researchers continue exploring cannabinoids for insomnia, advanced EEG technologies may help identify which patients are most likely to benefit while improving understanding of how these compounds influence the sleeping brain. The findings represent another step toward more precise, biologically informed approaches to treating sleep disorders and related psychiatric conditions.

Citations

Suraev A, McGregor IS, McCartney D, et al. Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia: A Pilot Randomised Controlled Trial. Journal of Sleep Research (2026). https://onlinelibrary.wiley.com/doi/10.1111/jsr.70015

Karina Petrova. How a Dose of Medicinal Cannabis Alters Brain Waves During Sleep. PsyPost, May 30, 2026. https://www.psypost.org/how-a-dose-of-medicinal-cannabis-alters-brain-waves-during-sleep/

Explore more at https://www.interventionalpsychiatry.org/

Interventional Psychiatry Network is on a mission to spread the word about the future of mental health treatments, research, and professionals. Learn more at www.interventionalpsychiatry.org/